A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil

Name: A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil
SKU: 8007
Availability: InStock

$0.00

A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil

By Robert Risinger, Marjie Hard, Peter J. Weiden

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 47 No. 3 Articles - 2017 Tags: antipsychotic-agents, aripiprazole, aripiprazole-lauroxil, marjie-hard, peter-j-weiden, prodrugs, psychomotor-agitation, psychopharmacology, robert-risinger, schizophrenia, weight-gain

Description

Description

A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil

By Robert Risinger, Marjie Hard, Peter J. Weiden

A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil

Description

Agomelatine for Depression in Schizophrenia by Jochen Mutschler

Paliperidone Double-blind, Placebo- and Active-Controlled, Study

A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil

Description

Related products

Ethical Issues in Schizophrenia: Considerations for Treatment and Research

Ethical Issues In Schizophrenia: Considerations for Treatment and Research

Agomelatine for Depression in Schizophrenia by Jochen Mutschler

Paliperidone Double-blind, Placebo- and Active-Controlled, Study